{"id":"https://openalex.org/W2040938113","doi":"https://doi.org/10.1517/13543784.17.11.1693","title":"Experimental therapy for advanced renal cell carcinoma","display_name":"Experimental therapy for advanced renal cell carcinoma","publication_year":2008,"publication_date":"2008-10-15","ids":{"openalex":"https://openalex.org/W2040938113","doi":"https://doi.org/10.1517/13543784.17.11.1693","mag":"2040938113","pmid":"https://pubmed.ncbi.nlm.nih.gov/18922106"},"language":"en","primary_location":{"id":"doi:10.1517/13543784.17.11.1693","doi":"https://doi.org/10.1517/13543784.17.11.1693","is_oa":false,"landing_page_url":"https://doi.org/10.1517/13543784.17.11.1693","pdf_url":null,"source":{"id":"https://openalex.org/S131064935","display_name":"Expert Opinion on Investigational Drugs","issn_l":"1354-3784","issn":["1354-3784","1744-7658"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Investigational Drugs","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5102785664","display_name":"Thomas E. Hutson","orcid":"https://orcid.org/0000-0002-4529-4212","observed_orcids":["https://orcid.org/0000-0002-4529-4212"]},"institutions":[{"id":"https://openalex.org/I2800124591","display_name":"Texas Oncology","ror":"https://ror.org/02ketev28","country_code":"US","type":"facility","lineage":["https://openalex.org/I2800124591"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas E Hutson","raw_affiliation_strings":["Baylor Sammons Cancer Center, Genitourinary Oncology Program, Texas Oncology, PA, Dallas, Texas 75246, USA. thomas.hutson@usoncology.com","+1 214 370 1902","Baylor Sammons Cancer Center, Genitourinary Oncology Program, Texas Oncology, PA, Dallas, Texas 75246, USA +1 214 370 1000"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Baylor Sammons Cancer Center, Genitourinary Oncology Program, Texas Oncology, PA, Dallas, Texas 75246, USA. thomas.hutson@usoncology.com","institution_ids":[]},{"raw_affiliation_string":"+1 214 370 1902","institution_ids":[]},{"raw_affiliation_string":"Baylor Sammons Cancer Center, Genitourinary Oncology Program, Texas Oncology, PA, Dallas, Texas 75246, USA +1 214 370 1000","institution_ids":["https://openalex.org/I2800124591"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5050649350","display_name":"Robert A. Figlin","orcid":"https://orcid.org/0000-0002-6323-6075","observed_orcids":["https://orcid.org/0000-0002-6323-6075"]},"institutions":[{"id":"https://openalex.org/I1301076528","display_name":"City Of Hope National Medical Center","ror":"https://ror.org/00w6g5w60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301076528"]},{"id":"https://openalex.org/I4210110459","display_name":"City of Hope","ror":"https://ror.org/01z1vct10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301076528","https://openalex.org/I4210110459"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert A Figlin","raw_affiliation_strings":["City of Hope Comprehensive Cancer Center, 1500 East Duarte Road, Duarte, CA 91010, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"City of Hope Comprehensive Cancer Center, 1500 East Duarte Road, Duarte, CA 91010, USA","institution_ids":["https://openalex.org/I1301076528","https://openalex.org/I4210110459"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.3698,"has_fulltext":false,"cited_by_count":7,"citation_normalized_percentile":{"value":0.32205128,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"17","issue":"11","first_page":"1693","last_page":"1702"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/renal-cell-carcinoma","display_name":"renal cell carcinoma","score":0.7960000038146973},{"id":"https://openalex.org/keywords/metastatic-renal-cell-carcinoma","display_name":"metastatic renal cell carcinoma","score":0.9620000123977661},{"id":"https://openalex.org/keywords/novel-therapeutic-targets","display_name":"novel therapeutic targets","score":0.5600000023841858},{"id":"https://openalex.org/keywords/vegf-inhibition","display_name":"VEGF inhibition","score":0.7519999742507935},{"id":"https://openalex.org/keywords/sunitinib","display_name":"sunitinib","score":0.9240000247955322},{"id":"https://openalex.org/keywords/sorafenib","display_name":"sorafenib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.9919999837875366},{"id":"https://openalex.org/keywords/interferon-alpha","display_name":"interferon-alpha","score":0.8309999704360962},{"id":"https://openalex.org/keywords/temsirolimus","display_name":"temsirolimus","score":0.9789999723434448},{"id":"https://openalex.org/keywords/everolimus","display_name":"everolimus","score":0.9990000128746033},{"id":"https://openalex.org/keywords/mtor-inhibitors","display_name":"mTOR inhibitors","score":0.6480000019073486},{"id":"https://openalex.org/keywords/clinical-trials","display_name":"clinical trials","score":0.38199999928474426}],"concepts":[{"id":"https://openalex.org/C2776820818","wikidata":"https://www.wikidata.org/wiki/Q7699074","display_name":"Temsirolimus","level":5,"score":0.9314700365066528},{"id":"https://openalex.org/C2778695046","wikidata":"https://www.wikidata.org/wiki/Q421136","display_name":"Sorafenib","level":3,"score":0.8475342392921448},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8291666507720947},{"id":"https://openalex.org/C2779490328","wikidata":"https://www.wikidata.org/wiki/Q417542","display_name":"Sunitinib","level":3,"score":0.7953128814697266},{"id":"https://openalex.org/C2777472916","wikidata":"https://www.wikidata.org/wiki/Q1164529","display_name":"Renal cell carcinoma","level":2,"score":0.7633840441703796},{"id":"https://openalex.org/C2908861226","wikidata":"https://www.wikidata.org/wiki/Q417542","display_name":"Sunitinib malate","level":4,"score":0.7038109302520752},{"id":"https://openalex.org/C2779699572","wikidata":"https://www.wikidata.org/wiki/Q421052","display_name":"Everolimus","level":2,"score":0.6524431705474854},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.6511309146881104},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5976952314376831},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.569060206413269},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.517340362071991},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.49386078119277954},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.42117607593536377},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2679639458656311},{"id":"https://openalex.org/C183713625","wikidata":"https://www.wikidata.org/wiki/Q5282002","display_name":"Discovery and development of mTOR inhibitors","level":4,"score":0.2513466477394104},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.1964784860610962},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.12774544954299927},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.10745495557785034},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.08812147378921509},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002292","descriptor_name":"Carcinoma, Renal Cell","qualifier_ui":"Q000098","qualifier_name":"blood supply","is_major_topic":false},{"descriptor_ui":"D002292","descriptor_name":"Carcinoma, Renal Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002292","descriptor_name":"Carcinoma, Renal Cell","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002292","descriptor_name":"Carcinoma, Renal Cell","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009362","descriptor_name":"Neoplasm Metastasis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009367","descriptor_name":"Neoplasm Staging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1517/13543784.17.11.1693","doi":"https://doi.org/10.1517/13543784.17.11.1693","is_oa":false,"landing_page_url":"https://doi.org/10.1517/13543784.17.11.1693","pdf_url":null,"source":{"id":"https://openalex.org/S131064935","display_name":"Expert Opinion on Investigational Drugs","issn_l":"1354-3784","issn":["1354-3784","1744-7658"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Investigational Drugs","raw_type":"journal-article"},{"id":"pmid:18922106","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18922106","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert opinion on investigational drugs","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":61,"referenced_works":["https://openalex.org/W147958728","https://openalex.org/W1965734230","https://openalex.org/W1980013575","https://openalex.org/W1999966467","https://openalex.org/W2000343782","https://openalex.org/W2000975023","https://openalex.org/W2003224526","https://openalex.org/W2014404252","https://openalex.org/W2019749043","https://openalex.org/W2043517828","https://openalex.org/W2050026229","https://openalex.org/W2059108446","https://openalex.org/W2059742276","https://openalex.org/W2088807388","https://openalex.org/W2097841033","https://openalex.org/W2100669312","https://openalex.org/W2112901840","https://openalex.org/W2115516828","https://openalex.org/W2116928781","https://openalex.org/W2119974083","https://openalex.org/W2120129511","https://openalex.org/W2120906137","https://openalex.org/W2123666705","https://openalex.org/W2129638180","https://openalex.org/W2134659609","https://openalex.org/W2140837341","https://openalex.org/W2143813821","https://openalex.org/W2147081651","https://openalex.org/W2149456801","https://openalex.org/W2153867442","https://openalex.org/W2158749015","https://openalex.org/W2160329331","https://openalex.org/W2166259130","https://openalex.org/W2168282586","https://openalex.org/W2170056895","https://openalex.org/W2201134166","https://openalex.org/W2206164324","https://openalex.org/W2210929914","https://openalex.org/W2224331650","https://openalex.org/W2224540931","https://openalex.org/W2225151298","https://openalex.org/W2231357634","https://openalex.org/W2241761252","https://openalex.org/W2244980948","https://openalex.org/W2247471250","https://openalex.org/W2247544749","https://openalex.org/W2249383714","https://openalex.org/W2262509800","https://openalex.org/W2277365070","https://openalex.org/W2282440226","https://openalex.org/W2325164446","https://openalex.org/W2337968495","https://openalex.org/W2399474082","https://openalex.org/W2529558146","https://openalex.org/W2533492923","https://openalex.org/W2589523300","https://openalex.org/W2595416856","https://openalex.org/W2597686203","https://openalex.org/W2944460938","https://openalex.org/W3009126648","https://openalex.org/W3010187320"],"related_works":["https://openalex.org/W2074027443","https://openalex.org/W1972705538","https://openalex.org/W1971397741","https://openalex.org/W2104150907","https://openalex.org/W2470466748","https://openalex.org/W2949529108","https://openalex.org/W2096264404","https://openalex.org/W2113562909","https://openalex.org/W99290919","https://openalex.org/W2013408555"],"abstract_inverted_index":{"BACKGROUND:":[0],"The":[1,73],"treatment":[2],"of":[3,46,60,75,87,103,149],"metastatic":[4,155],"renal":[5],"cell":[6],"carcinoma":[7],"(RCC)":[8],"has":[9],"changed":[10],"dramatically":[11],"over":[12],"the":[13,38,147],"past":[14],"few":[15],"years.":[16],"Sunitinib":[17],"malate,":[18],"sorafenib":[19],"tosylate,":[20],"bevacizumab":[21],"+/-":[22],"interferon-alfa,":[23],"temsirolimus,":[24],"and":[25,40,44,109,112,139],"everolimus":[26],"have":[27,121],"improved":[28],"clinical":[29,57,141],"outcomes":[30],"in":[31,56,91,114,126],"randomized":[32],"Phase":[33],"III":[34],"trials":[35,142],"by":[36],"inhibiting":[37],"VEGF":[39],"related":[41],"pathways.":[42],"Combinations":[43],"sequences":[45],"these":[47,150],"agents":[48,54,80,120,151],"are":[49,55],"being":[50],"evaluated.":[51],"Other":[52],"novel":[53,63,89],"development,":[58],"some":[59],"which":[61],"target":[62],"pathways":[64],"not":[65],"yet":[66],"exploited":[67],"as":[68,132,152],"therapy":[69,133,153],"for":[70,93,134,154],"RCC.":[71,95,136,156],"OBJECTIVE:":[72],"objective":[74],"this":[76],"review":[77,102],"on":[78],"experimental":[79,119],"is":[81],"to":[82,106],"provide":[83],"a":[84],"comprehensive":[85],"overview":[86],"evolving":[88],"therapies":[90,98],"development":[92],"advanced":[94,135],"METHODS:":[96],"Experimental":[97],"were":[99],"identified":[100],"through":[101],"abstracts":[104],"submitted":[105],"recent":[107],"meetings,":[108],"manuscripts":[110],"published":[111],"indexed":[113],"Medline/PubMed":[115],"databases.":[116],"RESULTS/CONCLUSION:":[117],"Several":[118],"shown":[122],"significant":[123],"antitumor":[124],"activity":[125],"early":[127],"studies,":[128],"with":[129],"potential":[130],"application":[131],"Recently":[137],"reported":[138],"ongoing":[140],"will":[143],"help":[144],"further":[145],"define":[146],"role":[148]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}